thalidomide has been researched along with ceruletide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crisafulli, C; Cuzzocrea, S; Di Paola, R; Genovese, T; Malleo, G; Mazzon, E; Muià, C; Siriwardena, AK | 1 |
Brito, GA; Chaves, MH; Melo, CM; Morais, TC; Rao, VS; Santos, FA; Tomé, AR | 1 |
Chen, C; Chen, SH; Chiu, TH; Huang, YT; Tsai, MJ | 1 |
3 other study(ies) available for thalidomide and ceruletide
Article | Year |
---|---|
Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis.
Topics: Animals; Apoptosis; Ceruletide; Disease Models, Animal; Immunologic Factors; Intercellular Adhesion Molecule-1; Interleukin-1beta; Male; Mice; Neutrophils; P-Selectin; Pancreatitis, Acute Necrotizing; Thalidomide; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2008 |
Anti-inflammatory effect of α,β-amyrin, a triterpene from Protium heptaphyllum, on cerulein-induced acute pancreatitis in mice.
Topics: Amylases; Animals; Anti-Inflammatory Agents; Burseraceae; Ceruletide; Disease Models, Animal; Immunosuppressive Agents; Interleukin-6; Male; Mice; Nitric Oxide Synthase Type II; Oleanolic Acid; Pancreatitis; Peroxidase; Random Allocation; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Pomalidomide suppresses cerulein-induced acute pancreatitis in mice.
Topics: Acute Disease; Administration, Oral; Amylases; Animals; Ceruletide; Disease Models, Animal; Immunologic Factors; Lipase; Male; Mice; Mice, Inbred C57BL; Pancreatitis; Severity of Illness Index; Thalidomide | 2011 |